Cipla Ltd. engages in the manufacture and distribution of healthcare products and bulk drugs. Its products portfolio include prescription drugs, animal healthcare products, bulk drugs, OTC products, agrochemicals and technology. The company offers technology services such as consulting, project appraisal, engineering, plant supply, commissioning, training, know-how transfer and quality control. It operates through the following geographical segments: India, USA, South Africa, and Rest of the World. Cipla was founded by Khwaja Abdul Hamied in 1935 and is headquartered in Mumbai, India.